The intermediate profit exceeds 5%
CCTV reporters have found that the bid price of some commonly used drugs is much higher than the ex-factory price after a year-long investigation. The reporter randomly selected 2 kinds of commonly used drugs, and found that the profit of these drugs from the factory to the hospital exceeded 5%. Many people in the pharmaceutical industry have reported that the ultra-high profits of drugs are by no means an individual phenomenon in the industry. People in the industry have provided some drug product price catalogues, involving the ex-factory price and hospital retail price of tens of thousands of drugs from hundreds of pharmaceutical factories. Some commonly used drugs used to treat pneumonia, gastritis and pain relief have an intermediate profit of more than 4% from factory to hospital retail. The two most outrageous drugs are: lappaconitine hydrobromide injection with the specification of 2ml and 4mg produced by Tianyao Group Xinzheng Co., Ltd., the ex-factory price is .52 yuan each, the bid price is 16 yuan, the retail price of the hospital is 18.4 yuan, and the intermediate profit exceeds 3,4% (3,438%); The specification of nefopam hydrochloride injection hydrochloride produced by Shandong Fangming Pharmaceutical Co., Ltd. is 2 ml and 2 mg. The ex-factory price is .32 yuan each, the bid price is 18.49 yuan, the retail price of the hospital is 21.26 yuan, and the intermediate profit is as high as 65%.
"ceiling price" is still too high
According to industry experts, the purpose of setting the maximum retail price of drugs is to limit the price of drugs and prevent them from being inflated, but the reality is that the maximum retail price of drugs called "ceiling price" is even higher than the ex-factory price. Take nefopam hydrochloride injection hydrochloride (2ml 2mg) produced by Shandong Fangming Pharmaceutical Company as an example. The ex-factory price is .32 yuan each, and the highest retail price is set at 35.9 yuan.
participation of hospitals and doctors
according to China's current centralized bidding method for drugs, all drugs used by public medical institutions must be purchased by bidding, and the price is approved and announced by the local provincial centralized drug procurement management office. The approved and published price is also called the winning bid price, which is the highest price of drugs purchased by hospitals, so the formulation of bidding price has become a decisive factor affecting the price of drugs. The reporter contacted the person in charge of a pharmaceutical factory. She revealed that the bidding and pricing of drugs were not operated by the pharmaceutical factory, but by a professional pharmaceutical agency. The ex-factory price of a commonly used medicine for treating gynecological diseases produced by this company is 7 yuan, and the bid price is as high as 56 yuan. This process follows the "hidden rules" of the industry. According to the person in charge, although the intermediate profit of this drug exceeds 8%, the pharmaceutical factory only earns about 1 yuan, and the difference between 7 yuan and 56 yuan is shared by medical representatives, pharmaceutical companies, hospitals and doctors in 49 yuan. During the investigation, an insider who has been engaged in the pharmaceutical wholesale industry for more than ten years confirmed the statement of the person in charge of this pharmaceutical factory. He said that this model of sharing interests is the "hidden rule" in the process of drug bidding.